Patients and carers are our #1 priority and essential
in every decision we make as a company.
What you need to know about our trial
RSO-021 drug is for patients that have exhausted first line therapy for mesothelioma and metastatic disease with pleural effusion
You’ll need an IPC (intrapleural catheter) or are willing to get an IPC
The drug is delivered weekly
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.